Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorOLIVEIRA, Ana Carolina Soares de-
dc.contributor.authorFARIAS, Rodrigo Pessoa de-
dc.contributor.authorCOSTA, Antonio Charlys da-
dc.contributor.authorSAUER, Mariana Melillo-
dc.contributor.authorBASSICHETTO, Katia Cristina-
dc.contributor.authorOLIVEIRA, Solange Maria Santos-
dc.contributor.authorCOSTA, Priscilla Ramos-
dc.contributor.authorTOMIYAMA, Claudia-
dc.contributor.authorTOMIYAMA, Helena Tomoko Iwashita-
dc.contributor.authorSABINO, Ester Cerdeira-
dc.contributor.authorKALLAS, Esper Georges-
dc.contributor.authorSANABANI, Sabri Saeed-
dc.identifier.citationVIROLOGY JOURNAL, v.9, article ID 223, 8p, 2012-
dc.description.abstractBackground: Because various HIV vaccination studies are in progress, it is important to understand how often inter- and intra-subtype co/superinfection occurs in different HIV-infected high-risk groups. This knowledge would aid in the development of future prevention programs. In this cross-sectional study, we report the frequency of subtype B and F1 co-infection in a clinical group of 41 recently HIV-1 infected men who have sex with men (MSM) in Sao Paulo, Brazil. Methodology: Proviral HIV-1 DNA was isolated from subject's peripheral blood polymorphonuclear leukocytes that were obtained at the time of enrollment. Each subject was known to be infected with a subtype B virus as determined in a previous study. A small fragment of the integrase gene (nucleotide 4255-4478 of HXB2) was amplified by nested polymerase chain reaction (PCR) using subclade F1 specific primers. The PCR results were further confirmed by phylogenetic analysis. Viral load (VL) data were extrapolated from the medical records of each patient. Results: For the 41 samples from MSM who were recently infected with subtype B virus, it was possible to detect subclade F1 proviral DNA in five patients, which represents a co-infection rate of 12.2%. In subjects with dual infection, the median VL was 5.3 x 10(4) copies/ML, whereas in MSM that were infected with only subtype B virus the median VL was 3.8 x 10(4) copies/ML (p > 0.8). Conclusions: This study indicated that subtype B and F1 co-infection occurs frequently within the HIV-positive MSM population as suggested by large number of BF1 recombinant viruses reported in Brazil. This finding will help us track the epidemic and provide support for the development of immunization strategies against the HIV.-
dc.description.sponsorshipBrazilian Program for STD and AIDS, Ministry of Health [914/BRA/3014-UNESCO/Kallas]-
dc.description.sponsorshipSao Paulo City Health Department [2004-0.168.922-7/Kallas]-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)[04/15856-9]-
dc.relation.ispartofVirology Journal-
dc.subject.otherdisease progression-
dc.subject.othertype-1 infection-
dc.titleFrequency of subtype B and F1 dual infection in HIV-1 positive, Brazilian men who have sex with men-
dc.rights.holderCopyright BIOMED CENTRAL LTD-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-, Ana Carolina Soares de:Univ Fed Sao Paulo, Dept Translat Med, Sao Paulo, Brazil-, Antonio Charlys da:Univ Fed Sao Paulo, Dept Translat Med, Sao Paulo, Brazil-, Mariana Melillo:Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil-, Katia Cristina:Publ Hlth Dept Sao Paulo, Sao Paulo, Brazil-, Claudia:Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil-, Helena Tomoko Iwashita:Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil-
hcfmusp.relation.referenceAndreani G, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-392-
hcfmusp.relation.referenceAnisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453-
hcfmusp.relation.referenceArien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594-
hcfmusp.relation.referenceARTENSTEIN AW, 1995, J INFECT DIS, V171, P805-
hcfmusp.relation.referenceBecker-Pergola G, 2000, AIDS RES HUM RETROV, V16, P1099, DOI 10.1089/088922200414938-
hcfmusp.relation.referenceBimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10-
hcfmusp.relation.referenceBlish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08-
hcfmusp.relation.referenceCarr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002-
hcfmusp.relation.referenceCheonis Nicholas, 2006, BETA, V18, P36-
hcfmusp.relation.referenceCohen OJ, 1998, NEW ENGL J MED, V339, P341, DOI 10.1056/NEJM199807303390511-
hcfmusp.relation.referenceCornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849-
hcfmusp.relation.referenceBatista MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005613-
hcfmusp.relation.referenceDIAZ RS, 1995, J VIROL, V69, P3273-
hcfmusp.relation.referenceDiaz RS, 2008, VIROLOGY, V381, P184, DOI 10.1016/j.virol.2008.08.014-
hcfmusp.relation.referenceGerhardt M, 2005, J VIROL, V79, P8249, DOI 10.1128/JVI.79.13.8249-8261.2005-
hcfmusp.relation.referenceGottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7-
hcfmusp.relation.referenceGrobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940-
hcfmusp.relation.referenceGunthard HF, 2009, CLIN INFECT DIS, V48, pE117, DOI 10.1086/598987-
hcfmusp.relation.referenceHall TA, 1999, NUCL ACIDS S SER, V41, P95, DOI 10.1111/J.1469-8137.2009.02874.X-
hcfmusp.relation.referenceHerbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599-
hcfmusp.relation.referenceHoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011-
hcfmusp.relation.referenceIversen AKN, 1999, J ACQ IMMUN DEF SYND, V22, P325-
hcfmusp.relation.referenceJanini LM, 1996, VIRUS GENES, V13, P69, DOI 10.1007/BF00576981-
hcfmusp.relation.referenceKallas Esper Georges, 2004, Braz J Infect Dis, V8, P399-
hcfmusp.relation.referenceKothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012-
hcfmusp.relation.referenceKozaczynska K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-59-
hcfmusp.relation.referenceLiu SL, 2002, J VIROL, V76, P10674, DOI 10.1128/JVI.76.21.10674-10684.2002-
hcfmusp.relation.referenceMANSKY LM, 1995, J VIROL, V69, P5087-
hcfmusp.relation.referenceMansky LM, 1996, VIROLOGY, V222, P391, DOI 10.1006/viro.1996.0436-
hcfmusp.relation.referenceNaidoo AF, 2009, AIDS RES HUM RETROV, V25, P1225, DOI 10.1089/aid.2009.0095-
hcfmusp.relation.referencePerelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582-
hcfmusp.relation.referencePernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73-
hcfmusp.relation.referencePiantadosi A, 2007, PLOS PATHOG, V3, P1745, DOI 10.1371/journal.ppat.0030177-
hcfmusp.relation.referenceRamos A, 1999, EMERG INFECT DIS, V5, P65-
hcfmusp.relation.referenceRedd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325-
hcfmusp.relation.referenceSagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003-
hcfmusp.relation.referenceSALA M, 1995, AIDS RES HUM RETROV, V11, P653, DOI 10.1089/aid.1995.11.653-
hcfmusp.relation.referenceSanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003-
hcfmusp.relation.referenceSanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869-
hcfmusp.relation.referenceSanabani SS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-78-
hcfmusp.relation.referenceSmith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009-
hcfmusp.relation.referenceSsemwanga D, 2012, AIDS RES HUM RETROV, V28, P357, DOI [10.1089/AID.2011.0024, 10.1089/aid.2011.0024]-
hcfmusp.relation.referenceSsemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025-
hcfmusp.relation.referenceTakehisa J, 1997, J ACQ IMMUN DEF SYND, V14, P81-
hcfmusp.relation.referenceTakehisa J, 1998, VIROLOGY, V245, P1, DOI 10.1006/viro.1998.9141-
hcfmusp.relation.referenceTamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121-
hcfmusp.relation.referenceTarosso LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011436-
hcfmusp.relation.referenceTempleton AR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-54-
hcfmusp.relation.referenceThompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876-
hcfmusp.relation.referenceThomson MM, 2001, AIDS, V15, P509, DOI 10.1097/00002030-200103090-00010-
hcfmusp.relation.referenceVandepitte J, 2011, SEX TRANSM DIS, V38, P316, DOI 10.1097/OLQ.0b013e3182099545-
hcfmusp.relation.referenceWiktor SZ, 1999, AIDS, V13, P695, DOI 10.1097/00002030-199904160-00010-
hcfmusp.relation.referenceYerly S, 2004, AIDS, V18, P1413, DOI 10.1097/01.aids.0000131330.28762.0c-
hcfmusp.relation.referenceZHU TF, 1995, J VIROL, V69, P1324-
hcfmusp.remissive.sponsorshipMinistério da Saúde-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - FM/MIP
Departamento de Moléstias Infecciosas e Parasitárias - FM/MIP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/52
LIM/52 - Laboratório de Virologia

Artigos e Materiais de Revistas Científicas - LIM/60
LIM/60 - Laboratório de Imunologia Clínica e Alergia

Files in This Item:
File Description SizeFormat 
art_COSTA_Frequency_of_subtype_B_and_F1_dual_infection_2012.PDFpublishedVersion (English)839.75 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.